Trials / Completed
CompletedNCT00557661
Safety Study of CD-NP in Heart Failure
A Multi-Center, Ascending Dose Trial to Assess the Safety, Pharmacokinetics and Pharmacodynamics of CD-NP Infusions in Patients With Congestive Heart Failure
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Nile Therapeutics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
An open-label study designed to determine the safety, tolerability and pharmacodynamics of CD-NP infusions in heart failure patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CD-NP | 24 hr intravenous infusion |
Timeline
- Start date
- 2007-11-01
- Completion
- 2008-12-01
- First posted
- 2007-11-14
- Last updated
- 2009-03-25
Source: ClinicalTrials.gov record NCT00557661. Inclusion in this directory is not an endorsement.